Gilead Sciences (GILD) Receivables - Other (2018 - 2025)
Historic Receivables - Other for Gilead Sciences (GILD) over the last 8 years, with Q3 2025 value amounting to $695.0 million.
- Gilead Sciences' Receivables - Other rose 27771.74% to $695.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $695.0 million, marking a year-over-year increase of 27771.74%. This contributed to the annual value of $277.0 million for FY2024, which is 13675.21% up from last year.
- As of Q3 2025, Gilead Sciences' Receivables - Other stood at $695.0 million, which was up 27771.74% from $305.0 million recorded in Q2 2025.
- In the past 5 years, Gilead Sciences' Receivables - Other registered a high of $695.0 million during Q3 2025, and its lowest value of $117.0 million during Q4 2023.
- Its 5-year average for Receivables - Other is $209.8 million, with a median of $167.0 million in 2021.
- Per our database at Business Quant, Gilead Sciences' Receivables - Other crashed by 3157.89% in 2023 and then soared by 27771.74% in 2025.
- Quarter analysis of 5 years shows Gilead Sciences' Receivables - Other stood at $174.0 million in 2021, then dropped by 1.72% to $171.0 million in 2022, then crashed by 31.58% to $117.0 million in 2023, then skyrocketed by 136.75% to $277.0 million in 2024, then soared by 150.9% to $695.0 million in 2025.
- Its last three reported values are $695.0 million in Q3 2025, $305.0 million for Q2 2025, and $304.0 million during Q1 2025.